111, Inc. Sponsored ADR

YI Healthcare Medical Distribution

111, Inc. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $1.8 billion, down 9.00% from fiscal 2024. In the quarter to March 2026, revenue fell 29.6%, EPS fell 200.0%, free cash flow fell 185.7% and total debt rose 82.5%, each against the same quarter a year earlier.

3.09 0.00 0.00%
Market cap
$16.0M
P/E
0.0×
Fwd P/E
0.0×
Dividend yield
—
F-score
5/9
Altman Z
3.31
Beneish M
−3.28
Dividend safety
n/a
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Piotroski F-Score
5 7 3 4 3 5 3 4 — —
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
3.31 3.36 2.82 2.36 2.23 1.69 0.61 0.36 — —
P/S ratio
0.01 0.00 0.01 0.01 0.01 0.05 0.10 0.00 0.00 0.00
P/FCF ratio
2.75 0.30 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z″-Score (non-manufacturers)
(5.61) (4.01) (4.56) (3.08) (3.14) (0.71) (2.02) 4.38 (2.55) 4.47
P/Operating CF
4.95 (0.64) (0.48) 2.89 (0.58) (2.42) (4.62) (1.65) 0.00 0.00
Beneish M-Score
(3.28) (3.12) (2.35) (3.17) (0.90) (1.89) 0.12 (1.81) (4.06) —
P/B ratio
0.00 0.00 0.00 0.00 0.00 0.92 0.50 0.14 0.00 0.00
Price to Tangible BV
0.00 0.00 0.00 0.00 0.00 0.93 0.50 0.14 0.00 0.00
EV/Sales
(0.02) (0.02) (0.02) (0.04) (0.04) (0.12) (0.06) 0.00 0.00 0.00
EV/EBITDA
112.75 0.00 0.68 1.53 0.78 2.15 0.44 0.00 0.00 0.00
EV/Operating CF
(2.25) (1.21) 0.53 24.56 0.72 8.70 0.43 0.00 0.00 0.00
EV/FCF
(4.73) (2.43) 0.40 3.30 0.62 5.86 0.43 0.00 0.00 0.00
Quick Ratio
0.45 0.40 0.44 0.52 0.63 1.09 0.99 3.61 2.39 4.28
Current Ratio
1.09 1.13 1.07 1.19 1.32 1.76 1.92 4.79 3.63 5.23
Net Debt/EBITDA
(44.78) (18.74) 1.02 2.25 1.11 3.03 1.25 2.84 1.93 1.74
Debt/Assets
8.53% 5.77% 10.94% 5.15% 8.25% 7.57% 5.90% 0.00% 0.00% 0.00%
Debt/Equity
(0.26) (0.24) (0.57) (0.44) (1.71) 0.56 0.12 0.00 0.00 0.00
Asset Turnover
5.16 4.83 4.49 3.93 4.07 3.62 2.49 1.53 0.97 0.77
Operating CF/Net income
(1.79) (4.06) 1.14 0.06 1.03 0.26 1.03 0.90 0.82 0.93
Capex/Depreciation
(0.37) (0.87) (0.38) (0.75) (2.29) (1.83) (2.09) (1.31) (0.46) 0.00
Interest Coverage
(0.07) 0.07 (17.38) (27.60) (117.03) (53.69) (136.32) (58.23) (4,798.62) —
ROE
9.82% 10.20% 77.35% 145.42% (547.31%) (80.68%) (49.64%) (313.93%) 31.08% 51.65%
ROA
(2.73%) (2.17%) (11.78%) (12.12%) (21.96%) (20.13%) (31.46%) (32.49%) (25.19%) (36.72%)
ROIC
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% (180.08%) (213.47%) 0.00% 0.00%
Return on Tangible Assets
(34.53%) (19.04%) (176.42%) (74.55%) (89.07%) (35.49%) (67.71%) (31.34%) (45.50%) (58.13%)
Average Days of Receivables
7.55 10.47 13.11 13.20 11.88 7.26 6.03 5.84 7.76 38.23
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 6.82%
Selling, General and Administrative Expense of Revenue
2.61% 2.67% 4.50% 4.91% 5.80% 6.43% 11.74% 20.09% 25.38% 43.94%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.01 0.00
Share Based Compensation of Revenue
0.08% 0.14% 1.52% 1.20% 1.17% 0.92% 1.37% 2.88% 1.03% 0.00%
Graham Net Nets
(5.12) (20.48) (7.60) (3.69) (2.68) 0.68 1.68 6.84 0.00 0.00
Graham Number
16.33 12.29 38.41 34.41 28.79 0.00 0.00 0.00 0.00 0.00
Earnings Yield
(39.06%) (103.23%) (400.00%) (242.62%) (365.71%) (117.99%) (133.73%) (6.51%) (4.35%) (4.35%)
Free Cash Flow Yield
36.37% 336.96% (596.26%) (98.40%) (434.90%) (46.40%) (133.63%) 0.00% 0.00% 0.00%
Revenue per Share
206.35 229.63 249.74 235.21 235.11 152.58 69.37 52.24 40.28 1.61
Operating CF per Share
1.96 4.19 (7.47) (0.40) (13.03) (2.17) (8.99) (10.03) (8.58) (0.71)
Capex per Share
(0.07) (0.23) (0.14) (0.53) (1.18) (0.48) (0.43) (0.43) (0.29) 0.00
Free Cash Flow per Share
1.89 3.96 (7.61) (0.93) (14.21) (2.65) (9.42) (10.46) (8.86) (0.71)
Cash per Share
10.05 8.26 11.26 16.06 17.85 30.11 12.25 32.37 19.36 1.12
Shareholders Equity per Share
(11.86) (10.49) (9.94) (7.11) (2.88) 7.56 13.58 35.79 (39.66) 1.92
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
(11.86) (10.49) (9.94) (7.11) (2.88) 7.56 13.58 35.79 (39.66) 1.92
Free Cash Flow
16.41 34.01 (64.14) (7.78) (117.88) (21.83) (77.11) (52.03) (31.91) (58.50)
Working Capital
24.48 42.07 26.52 74.05 105.41 190.50 101.70 173.45 79.99 104.85
Capital Expenditures
(0.62) (2.02) (1.15) (4.42) (9.79) (3.93) (3.51) (2.14) (1.03) (1.04)
Net Current Asset Value
(113.95) (109.08) (105.70) (93.76) (77.87) 38.72 92.66 172.27 (147.74) 104.85
EV/EBIT
112.72 0.00 0.68 1.53 0.78 2.15 0.44 0.00 0.00 0.00
Capex to Sales
0.00 0.00 0.00 0.00 0.01 0.00 0.01 0.01 0.01 0.00
Price to Operating Income
0.00 18.43 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
0.56 0.52 0.63 0.84 0.34 0.32 0.39 0.56 0.87 0.52
Cash ROIC
148.15% 1,173.30% (109.20%) (7.74%) (71.49%) (6.32%) (34.26%) (15.35%) 43.68% (23.40%)
Accounts Receivable Turnover
38.31 29.85 28.74 29.17 44.08 73.16 83.93 71.78 17.15 9.27
Accounts Payable Turnover
8.07 8.09 8.28 7.87 9.86 10.52 11.49 9.74 7.85 7.11
Inventory Turnover
10.17 9.54 9.52 9.35 12.63 12.82 10.82 9.33 6.21 5.55
Average Days of Payables
39.56 46.30 41.13 50.82 41.66 49.99 42.83 46.07 53.84 42.89
Days of Inventory on Hand
30.80 37.31 36.75 43.16 34.66 35.70 46.87 45.76 60.53 62.39
Average Receivables
46.87 66.10 73.25 67.18 44.23 17.18 6.76 3.62 8.45 14.24
Average Payables
209.61 229.80 239.82 233.65 187.96 114.16 47.35 25.12 16.73 16.89
Average Inventory
166.43 195.00 208.62 196.62 146.70 93.66 50.26 26.22 21.14 21.64
Average Assets
348.28 408.50 469.37 498.65 478.74 347.57 228.11 170.14 149.14 171.57
Average Common Equity
(96.67) (86.96) (71.51) (41.56) 19.20 86.73 144.58 17.61 (120.88) (121.97)

Fold the line items

Columns are period end dates